COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS
The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some e...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
03.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRa, PDGFRß) kinases.
La présente invention concerne des composés de formule (I) et (II) et des compositions pharmaceutiques en contenant, pouvant être utilisés en tant qu'inhibiteurs des protéines kinases, ainsi que des méthodes d'utilisation desdits composés à des fins de traitement, d'amélioration ou de prévention d'une affection associée à une activité anormale ou dérégulée des kinases. Dans certains modes de réalisation, l'invention concerne des méthodes d'utilisation desdits composés à des fins de traitement, d'amélioration ou de prévention des maladies ou affections impliquant une activation anormale des kinases c-kit ou c-kit et PDGFR (PDGFRa, PDGFRß). |
---|---|
AbstractList | The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRa, PDGFRß) kinases.
La présente invention concerne des composés de formule (I) et (II) et des compositions pharmaceutiques en contenant, pouvant être utilisés en tant qu'inhibiteurs des protéines kinases, ainsi que des méthodes d'utilisation desdits composés à des fins de traitement, d'amélioration ou de prévention d'une affection associée à une activité anormale ou dérégulée des kinases. Dans certains modes de réalisation, l'invention concerne des méthodes d'utilisation desdits composés à des fins de traitement, d'amélioration ou de prévention des maladies ou affections impliquant une activation anormale des kinases c-kit ou c-kit et PDGFR (PDGFRa, PDGFRß). |
Author | LIU, XIAODONG LOREN, JON YEH, VINCE NGUYEN, BAO PETRASSI, HANK MICHAEL JAMES MOLTENI, VALENTINA LI, XIAOLIN NABAKKA, JULIET |
Author_xml | – fullname: LOREN, JON – fullname: NGUYEN, BAO – fullname: LI, XIAOLIN – fullname: LIU, XIAODONG – fullname: PETRASSI, HANK MICHAEL JAMES – fullname: NABAKKA, JULIET – fullname: YEH, VINCE – fullname: MOLTENI, VALENTINA |
BookMark | eNrjYmDJy89L5WQwdfb3DfAP9XMJVnD0c1EA84I9Qzz9_YACwQrOut6eIQrenn6Owa4Knn4enk6eIf5BwTwMrGmJOcWpvFCam0HezTXE2UM3tSA_PrW4IDE5NS-1JN7Z0cjCxNTQ1NLZmLAKAFM_KJg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSES ET COMPOSITIONS POUVANT ETRE UTILISES EN TANT QU'INHIBITEURS DE LA KINASE C-KIT |
ExternalDocumentID | CA2845159C |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA2845159C3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:00:15 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA2845159C3 |
Notes | Application Number: CA20122845159 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201103&DB=EPODOC&CC=CA&NR=2845159C |
ParticipantIDs | epo_espacenet_CA2845159C |
PublicationCentury | 2000 |
PublicationDate | 20201103 |
PublicationDateYYYYMMDD | 2020-11-03 |
PublicationDate_xml | – month: 11 year: 2020 text: 20201103 day: 03 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | IRM LLC |
RelatedCompanies_xml | – name: IRM LLC |
Score | 3.2947671 |
Snippet | The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201103&DB=EPODOC&locale=&CC=CA&NR=2845159C |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB2VgoAbFFDZfUC5RajU2Q4RSuxECSiLmhT1VjnFFVzSigbx-9gmAS69eZHG9kgzz8u8McCdTPFk2JWjO7bJdGyZC93GjOmcGwJPljb7YXgnqRlN8dPMmPXgrePCqDyhXyo5orCohbD3Rvnr9d8lFlWxlZv76l00rR7D0qVaezpWaDbWqO8GeUYzohHiEk9LJ67wwhK5yQ7sik20JW0hePElJ2X9H1DCI9jLhay6OYYerwdwQLp_1wawn7TP3aLYWt7mBAySJXk2TWmBvJQiVStixQFGXoGI_hyXSBzFvSJAcRrFflxmk-IUbsOgJJEuxp__LnVOvG6i4zPo16uaDwHJSEyHYQdz6xUv2aga8QfLqphMrGLY3DmH4TYpF9u7LuFQKkzx6sZX0G8-Pvm1ANimulG6-QZ2SXnm |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB2Vgig3KKCy1geUW4RKsx4ilDiJEtosalLUW-S0ruCSVjSI38c2CXDpzYs0tkeaeV7mjQEeeIon1ShN2TQ0Iiu6tpQNhRCZUpXhydogPwzvKNaCufKyUBcdeGu5MCJP6JdIjsgsasnsvRb-evt3ieWK2MrdY_nOmjbPfm65UnM6Fmg2llzH8tLETbCEsYVtKZ5ZzAtz5MYHcMg22Dq3Be_V4ZyU7X9A8U_hKGWyqvoMOrTqQw-3_6714ThqnrtZsbG83TmoOInSZB67GbJjF4laFgoOMLIzhOVJmCN2FLczD4VxEDphnsyyCxj6Xo4DmY1f_C61wHY70fEldKtNRQeAeCSmSRRTofpKWZNROaJPul4SnlhFNah5BYN9Uq73dw2hF-TRtJiG8eQGTrjyBMdufAvd-uOT3jGwrct7oadvWUl82Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+AND+COMPOSITIONS+AS+C-KIT+KINASE+INHIBITORS&rft.inventor=LOREN%2C+JON&rft.inventor=NGUYEN%2C+BAO&rft.inventor=LI%2C+XIAOLIN&rft.inventor=LIU%2C+XIAODONG&rft.inventor=PETRASSI%2C+HANK+MICHAEL+JAMES&rft.inventor=NABAKKA%2C+JULIET&rft.inventor=YEH%2C+VINCE&rft.inventor=MOLTENI%2C+VALENTINA&rft.date=2020-11-03&rft.externalDBID=C&rft.externalDocID=CA2845159C |